Matinas BioPharma Holdings Inc (MTNB)

US · Healthcare · Biotechnology

$0.29-3.68%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Revenue YoY

-100.0%

Net profit

$-1.9M

Profit YoY

-16.0%

EPS

$-0.30

Market cap

$1.9M

Forward P/E

0.0

P/B

0.62

Book value

$0.47

EPS (TTM)

$-1.97

52-week high

$3.09

52-week low

$0.23

50-day MA

$0.59

200-day MA

$0.73

Beta

1.71

Analysts rate Matinas BioPharma Holdings Inc a hold (0 buy, 2 hold, 0 sell out of 2) with an average price target of $30.00.

Insiders

18.03%

Institutions

2.59%

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Matinas BioPharma Holdings Inc — free to start.

Data updated 2026-08-05.